doi: 10.1007/BF02217143.
1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy
- PMID: 7251289
- DOI: 10.1007/BF02217143
Item in Clipboard
1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy
Int Urol Nephrol.
1980.
Abstract
Renal osteodystrophy still poses major problems in the management of chronic renal failure, though it had been extensively studied over the last years. The present therapeutic possibilities - massive-dose vitamin D, aluminium hydroxide and supplementary Ca-intake, administration of active vitamin D metabolites - are discussed in the light of personal observations.
Similar articles
-
Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.Adv Exp Med Biol. 1978;103:473-86. doi: 10.1007/978-1-4684-7758-0_48. Adv Exp Med Biol. 1978. PMID: 362852 Review. No abstract available.
-
Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154. Kidney Int. 1980. PMID: 7014981 Review. No abstract available.
-
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.Proc Eur Dial Transplant Assoc. 1980;17:543-7. Proc Eur Dial Transplant Assoc. 1980. PMID: 6972529
-
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].Klin Wochenschr. 1980 May 16;58(10):511-9. doi: 10.1007/BF01477068. Klin Wochenschr. 1980. PMID: 7392529 German.
-
Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.Contrib Nephrol. 1980;18:55-71. doi: 10.1159/000403273. Contrib Nephrol. 1980. PMID: 7353380 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Medical